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Abstract Binding of the C-terminal binding protein, CtBP, to
the adenovirus E1A moiety of a Gal4-E1A fusion protein
abolishes conserved region (CR) 1-dependent transcription
activation. In contrast, a non-promoter targeted E1A peptide,
capable of binding CtBP, can induce transcription from the
proliferating cell nuclear antigen (PCNA) promoter. CtBP is
shown here to bind the histone deacetylase HDAC1, suggesting
that a promoter targeted CtBP-HDAC1 complex can silence
transcription from the PCNA promoter through a deacetylation
mechanism. Expression of the CtBP binding domain of E1A is
sufficient to alleviate repression, possibly due to the displacement
of the CtBP-HDAC1 complex from the promoter.
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1. Introduction
The major adenovirus E1A proteins (E1A-243R and E1A-
289R) [1] can redirect cellular processes by interacting with
key cellular regulatory proteins in order to achieve optimal
conditions for virus growth. Three conserved regions (CR)
have been identi¢ed and two of these, CR1 and CR2, are
present in both E1A-243R and E1A-289R, whereas the third
region, CR3, is unique to E1A-289R.
The E1A-289R protein is required for e⁄cient expression of
all adenovirus early genes and activates transcription through
a CR3-mediated interaction with both basal and upstream
binding transcription factors, and by inducing phosphoryla-
tion of speci¢c transcription factors (reviewed in [2]).
Transcription regulation by E1A-243R protein has strong
implications for the capacity of E1A to induce cellular trans-
formation. The activities of E1A-243R engage the CR1, CR2
and the amino-terminus in physical interactions with proteins
controlling cell-cycle progression (reviewed in [3]). Targeting
of cellular regulatory complexes by E1A can result in their
dissociation, as exempli¢ed by the E1A induced release of the
transcription factor E2F from inhibitory complexes with
members of the family of retinoblastoma proteins (reviewed
in [4]), leading to induction of S-phase and DNA synthesis.
Alternatively, E1A binding may directly interfere with the
activity of the targeted protein, as in the case of E1A binding
and inhibition of the cyclin-dependent kinase inhibitor
p27Kip1, thereby restoring the activity of the cyclin E-cdk2
kinase complex [5].
E1A-243R can also regulate transcription by directly inter-
acting with speci¢c transcription factors or the transcription
co-activator proteins p300 and CREB binding protein (CBP).
Binding of E1A has been shown to prevent the co-activator
function of p300/CBP most likely by disrupting a complex
between p300/CBP and the histone acetylase P/CAF [6], there-
by interfering with a proposed chromatin remodelling activity
of p300/CBP-P/CAF. Direct targeting of transcription factors
and disruption of inhibitory complexes are also a common
theme in transcription regulation by E1A-243R. Activation
of the c-fos promoter by E1A involves the relief of YY1
mediated repression through a disruption of the ATF/
CREB-YY1 complex [7] and E1A activation of the hsp70
promoter has been suggested to occur through the dissocia-
tion of the transcription inhibitor Dr1 from TBP [8].
Although transcription regulatory activities have also been
demonstrated for the second exon of E1A, little is known
about their mechanisms. Redundant sequences encoded by
the second exon have been shown to activate viral gene ex-
pression independently of the ¢rst exon [9]. Speci¢cally, the
auxiliary regions (AR) 1 and 2 individually enhance CR3
dependent activation of the E4F transcription factor [10]. Fur-
thermore, AR2 is also speci¢cally required for the restricted
metastatic properties of co-transformed cells, possibly through
its ability to repress metalloprotease gene expression [11]. The
second exon of E1A is dispensable for co-transformation with
activated ras [12] and has in fact a general ability to inhibit in
vitro transformation, tumorigenesis and metastasis. These
events correlate with a speci¢c interaction between the car-
boxy-terminus of E1A and the cellular C-terminal binding
protein (CtBP) [13,14].
We have previously shown that a minimal region of E1A,
encompassing mainly CR1, constitutes a potent transcription
activator when expressed as a Gal4 fusion protein [15]. In
contrast, a larger Gal4E1A fusion protein, expressing also
the CtBP binding site, was inactive as a transactivator protein,
suggesting that recruitment of CtBP to a promoter results in
silencing of CR1 dependent transactivation [16]. Here we
show that the second exon of E1A alone was able to activate
transcription of the proliferating cell nuclear antigen (PCNA)
promoter. Since we also demonstrate that CtBP can interact
with a histone deacetylase (HDAC1), we propose that the
second exon of E1A can activate transcription by disrupting
a promoter bound complex containing CtBP and HDAC1,
thereby possibly preventing negative chromatin remodeling.
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2. Materials and methods
2.1. Plasmids
PCNACAT [17] contains a region spanning from 387 to +60 from
the PCNA promoter driving the CAT gene. PEREx3Luc contains a
trimer of the E1A responsive PCNA promoter element (359 to 345)
upstream of the basal PCNA promoter (345 to +60). PCNAvPER-
ELuc is a derivative of PEREx3Luc lacking the PERE repeats. Plas-
mids encoding the E1A-243R protein and its derivatives have been
described (pML00512S, pML00512SvCR1, pML00512Sv225^238 and
pML00512SvCR1,v225^238) [16,18]. E1A-243R denotes the full-
length protein, 243RvCR1 lacks amino acids 38^65, 243RvCB lacks
amino acids 225^238 and 243RvCR1,CB lacks amino acids 38^65 and
225^238. Exon2 denotes an E1A protein expressed from the second
exon of E1A only (dl1119, [9]) and exon2vCB a variant lacking amino
acids 225^238 (dl1135, [14]). Glutathione S-transferase (GST) fusion
protein GSTctE1A [16] expresses amino acids 200^243 of E1A-243R
and GSTCtBP [13] expresses the full-length CtBP protein. pcDNA3-
CtBP expresses the full-length CtBP protein [13].
HDAC1 encoding plasmids for in vitro translation (pING14A-
HDAC-1) and haemagglutinin-tagged for in vivo expression
(pCMV5P3THDAC-1) were kindly provided by Dr. T. Kouzarides.
2.2. Cell culture conditions and transfection and reporter gene
analysis
The human osteosarcoma cell line U2OS was maintained in
DMEM supplemented with 10% NCS, 100 U/ml penicillin, 100 Wg/
ml streptomycin and 2 mM L-glutamine. Transfections were done by
the calcium phosphate co-precipitation technique essentially as de-
scribed in [19], or by using the Lipofectamine transfection system
from Gibco as described by the manufacturers. The amounts of trans-
fected plasmids are indicated in the ¢gure legends. Cells were har-
vested at approximately 48 h post-transfection.
Chloramphenicol acetyltransferase assays were performed essen-
tially as described previously [20]. The cell extracts were prepared
by freeze-thawing three times in 0.25 M Tris-HCl, pH 7.5, and the
results were quantitated using the ImageQuant computer program on
a Phosphorimager (Molecular Dynamics). Luciferase assays were per-
formed by using the Luciferase Assay System from Promega accord-
ing to the manufacturers’ instructions. The results were quantitated
using a Luminometer (Labsystem).
2.3. In vitro binding analyses
The commercially available TNT T7 or SP6 coupled wheat germ or
coupled reticulocyte system from Promega were used according to the
manufacturers’ instructions. DNA templates for E1A-243R and E1A-
234RvCB were synthesized by PCR using an N-terminal primer har-
boring a T7 promoter and a sequence complementary to the trans-
lation initiation region of E1A. The DNA templates were puri¢ed by
using the PCR Puri¢cation Kit from Boehringer Mannheim Biochem-
icals according to the manufacturers’ instructions. Full-length CtBP
and HDAC1 were synthesized directly from plasmid pcDNA3-CtBP
[13] and pING14AHDAC-1, respectively.
U2OS cells were labeled with 600 WCi [32P]orthophosphate/60-mm
Petri dish for 4 h, washed with PBS and disrupted in WCE bu¡er (25
mM HEPES pH 7.6, 300 mM NaCl, 1.5 mM MgCl2, 0.2 mM EDTA,
0.1% Triton X-100, 0.5 mM DTT) supplemented with protease inhib-
itors (10 Wg/ml leupeptin, 10 Wg/ml pepstatin, 1 Wg/ml aprotinin and
0.4 mM pefablock) rotating at 4‡C for 30 min. Cell debris was re-
moved by centrifugation. Cell lysate was diluted four times in WCEv
bu¡er (25 mM HEPES pH 7.6, 1.5 mM MgCl2, 0.2 mM EDTA, 0.5
mM DTT) supplemented with protease inhibitors as above, and pre-
cleared with glutathione agarose beads (Pharmacia).
GST fusion proteins were produced in E. coli and bound to gluta-
thione Sepharose beads (Amersham Pharmacia Biotech) essentially as
described in Current Protocols in Molecular Biology. Protein concen-
tration was estimated on a Coomassie stained SDS-polyacrylamide
gel. Approximately equal amounts of GST fusion proteins were mixed
with [32P]orthophosphate labeled crude protein extract or 35S-labeled
in vitro translated proteins in binding bu¡er (¢nal concentration: 25
mM HEPES pH 7.6, 75 mM NaCl, 1.5 mM MgCl2, 0.2 mM EDTA,
0.025% Triton X-100) and incubated rotating at 4‡C for 3 h. Beads
were washed four times in HEPES binding bu¡er (20 mM HEPES pH
7.6, 50 mM NaCl, 2.5 mM MgCl2, 0.1 mM EDTA, 0.05% Triton X-
100 supplemented with a cocktail of protease inhibitor from Boehr-
inger Mannheim Biochemicals) and bound proteins were separated on
a 12% SDS-polyacrylamide gel and visualized by autoradiography.
2.4. Immunoprecipitations and Western blots
U2OS cells were labeled with 200 WCi [35S]methionine/60-mm Petri
dish for 4 h, washed with PBS and disrupted in lysis bu¡er (0.1% NP-
40, 250 mM NaCl, 50 mM HEPES pH 7.0, supplemented with a
cocktail of protease inhibitors from Boehringer Mannheim Biochem-
icals), on ice for 20 min. Cell debris was removed by centrifugation.
The lysate was precleared with protein A Sepharose CL-4B conjugate
(Amersham Pharmacia Biotech) followed by 1 h incubation with 1.0
Wg of the anti-haemagglutinin (HA) antibody SCP-12CA5-1 (Berkeley
Antibody Company) or with CtBP antiserum (kindly provided by Dr.
Chinnadurai). Protein A Sepharose was added and incubation was
continued rotating at 4‡C for 1 h followed by centrifugation to collect
immunoprecipitates. Precipitates were washed in lysis bu¡er four
times and bound proteins were separated on a 12% SDS-polyacryl-
amide gel and visualized by autoradiography.
For Western blot the immunoprecipitated proteins were transferred
from the 12% SDS-polyacrylamide to nitrocellulose ¢lters. The ¢lters
were blocked in 5% non-fat dry milk in TBS-T (20 mM Tris pH 7.5,
140 mM NaCl, 0.25% Tween 20) for 1 h at room temperature and
incubated overnight at 4‡C with anti-haemagglutinin (HA) antibody,
diluted 1:750. Hybridized proteins were detected using enhanced
chemiluminescence as described by the manufacturers (Amersham).
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Fig. 1. Requirements for CR1 and the CtBP binding region in
transactivation of the PCNA promoter. U2OS cells were cotrans-
fected with 8 Wg of PCNACAT and 8 Wg the indicated E1A con-
structs. At 48 h post-transfection, cell extracts were prepared and
analyzed for CAT activity. E1A-243R denotes the full-length E1A
protein. 243RvCB, 243RvCR1 and 243RvCR1,CB indicate deriva-
tives of E1A-243R harboring a deletion of aa 225^238, 38^65 or
both, respectively. Schematic representation of the E1A constructs
and PCNACAT are shown at the top. CB; CtBP binding region.
The relative expression from PCNACAT in the presence of vector
alone (3) was set at 1. The result shown is a representative from at
least three individual experiments.
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3. Results
3.1. E1A-243R transactivation of the PCNA promoter requires
the CtBP binding region of E1A
We have previously shown that transactivation by a Gal4
fusion protein expressing the conserved region 1 (CR1) of the
adenovirus type 2 E1A protein is e⁄ciently repressed by the
presence of the CtBP binding region (CB, amino acids 225^
238 of E1A-243R) [16]. Since these experiments were per-
formed using arti¢cial DNA binding of the CR1 activator
to a synthetic promoter, we continued to investigate the e¡ect
of the CtBP binding region on a previously characterized
E1A-243R-responsive promoter. In this report we present
data using the proliferating cell nuclear antigen (PCNA) pro-
moter, but similar results were also obtained using the adeno-
virus major late promoter (Sundqvist et al., unpublished).
To study the e¡ect of CtBP on E1A-243R mediated trans-
activation, a CAT reporter under the transcriptional control
of the proximal PCNA promoter element (387 to +60) (Fig.
1), was tested in a co-transfection assay in U2OS cells. As
expected from previous reports [21], E1A-243R activation of
PCNACAT was signi¢cantly reduced by deletion of CR1
(243RvCR1). Interestingly, a mutant lacking the CtBP bind-
ing region (243RvCB) also displayed reduced ability to induce
transcription and the double mutant 243RvCR1,CB, lacking
both CR1 and the CtBP binding region, was severely impaired
in its capacity to induce transcription from the PCNA pro-
moter. From these results we conclude that e⁄cient E1A-
243R mediated transactivation of the PCNA promoter re-
quires both CR1 and the CtBP binding region.
Western blot analyses con¢rmed that the observed e¡ects
were not due to poor expression of any of the E1A constructs
(data not shown).
3.2. The defective transactivation capacity of the E1A-243R
mutant lacking the CtBP binding domain is restored by
co-expression of the second exon of E1A
The requirement of the CtBP binding region for E1A-243R-
mediated activation of the PCNA promoter can be explained
by either of two di¡erent models; CtBP (or possibly another
protein binding to the same region of E1A) is an essential co-
factor for E1A-243R mediated transactivation, or alterna-
tively, CtBP might act as a repressor of transcription, which
is sequestered and inactivated through its interaction with
E1A.
To discriminate between these two models, experiments
were performed in which E1A-243R derivatives expressing
only the second exon of E1A were used as competitors for
CtBP binding (Fig. 2). U2OS cells were transfected with E1A-
243R or 243RvCB in the presence of indicated competitor
and the level of induction of the PCNA promoter was deter-
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Fig. 3. The second exon encoded protein activates transcription in-
dependent of the ¢rst exon encoded region and the CR1 responsive
PERE. Activation of PEREx3Luc and PCNAvPERELuc were de-
termined after cotransfection of U2OS cells with 2 Wg reporter with
1 Wg of plasmids encoding exon2 or exon2vCB. The relative expres-
sion from each reporter in the presence of vector alone (3) was set
at 1. The result shown is a representative from at least three indi-
vidual experiments.
Fig. 2. Co-expression of a E1A second exon encoded protein with
binding site for the CtBP restored maximal activation of the PCNA
promoter. U2OS cells were co-transfected with 8 Wg of plasmids en-
coding either E1A-243R or 243RvCB (Activator) and 4 Wg of plas-
mids encoding a protein from the second exon either with (exon2)
or without the CtBP binding region (exon2vCB) (Competitor).
Transcription activation was measured on the PCNACAT reporter
(6.5 Wg). The relative expression from PCNACAT in the presence of
vector alone (3) was set at 1. The result shown is a representative
from at least three individual experiments.
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mined. The competitor devoid of the CtBP binding region,
exon2vCB, had no e¡ect on PCNACAT expression, induced
by either E1A-243R or 243RvCB (Fig. 2). In contrast, the
intact exon2 competitor, which encoded a functional CtBP
binding site, e⁄ciently restored the reduced transactivation
capacity of 243RvCB (Fig. 2). Moreover, CAT activity in
cells expressing E1A-243R was also increased further in the
presence of exon2.
These results supported the second model which suggests
that CtBP acts as a repressor of PCNA promoter directed
transcription. Sequestering of CtBP, by binding to an excess
of the E1A second exon, alleviates the repression.
3.3. The second exon of E1A-243R is su⁄cient to induce
transcription from the PCNA promoter
The second exon of E1A alone has previously been postu-
lated to use redundant mechanisms to activate transcription of
several viral genes [9]. The ability of the second exon alone,
and particularly the CtBP binding region, to transactivate the
cellular PCNA promoter was therefore tested. As seen in Fig.
3, co-transfection of the PEREx3Luc reporter with exon2 re-
sulted in an approximately 3.5-fold increase in expression. In
contrast, exon2vCB, lacking the CtBP binding site, failed to
induce PEREx3Luc expression (Fig. 3). The level of protein
expression from the second exon constructs were determined
by Western blot analysis and found to be identical (data not
shown).
Induction of the PCNA promoter by E1A-243R has previ-
ously been shown to require the PERE (PCNA-E1A Respon-
sive Element) and to act via the CREB-CBP pathway [22]. To
analyze whether second exon activation required the same
target sequence, the PERE element was deleted from PER-
Ex3Luc creating PCNAvPERELuc, which contains only the
PCNA basal promoter element (347 to +60). As expected
[21,23], PEREx3Luc, but not PCNAvPERELuc, served as a
target for CR1 dependent transactivation (data not shown). In
contrast, co-expression of the E1A second exon constructs
showed that both PEREx3Luc and PCNAvPERELuc were
activated by exon2, but not by exon2vCB (Fig. 3).
Taken together with the results presented in Fig. 2, the data
suggests that the CtBP binding region constitutes a novel
transactivating domain within E1A-243R and that this do-
main activates transcription of the PCNA promoter in the
absence of ¢rst exon sequences and independent of the
PERE. Based on the speci¢c behavior of mutants lacking
the CtBP binding region, we propose that the protein repres-
sing the PCNA promoter directed transcription is indeed
CtBP.
3.4. CtBP expressed in U2OS cells binds to the C-terminus
of E1A-243R
Human CtBP is an abundant 48-kDa phosphoprotein [14].
To verify that CtBP was also present in U2OS cells an in vitro
binding experiment was performed. In a GST pull-down ex-
periment GSTctE1A, expressing the last 44 amino acids of
E1A, was challenged with [32P]orthophosphate labeled
U2OS whole cell extract (Fig. 4). An interaction with a 48-
kDa protein was seen with GSTctE1A but not with GST
alone. The identi¢cation of the 48-kDa protein as CtBP was
corroborated by the similar migration pattern of in vitro
translated radiolabeled CtBP (Fig. 4). Furthermore, since
CtBP previously has been shown to be the only phosphopro-
tein in the 48-kDa size range interacting with the C-terminus
of E1A [14], this experiment indicated that CtBP capable of
binding E1A was present in U2OS cells.
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Fig. 5. Interactions between CtBP and HDAC1 or E1A. A: GST
pull down experiment. Binding of in vitro translated E1A-243R,
243RvCB, or HDAC1 to GST and GSTCtBP, respectively. The in
vitro translated proteins are shown in the left panel. Equal amounts
of the in vitro translated proteins were incubated with indicated
GST proteins. B: Left panel: [35S]Methionine labeled extracts from
U2OS cells untransfected (3) or transfected with a plasmid encod-
ing hemagglutinin tagged HDAC1 (HDAC1) were immunoprecipi-
tated with the K-HA antibody (SCP-12CA5-1) or polyclonal antise-
rum raised against CtBP. Right panel: The same immuno-
precipitates were subjected to Western blotting and hybridized to
the K-HA antibody. For both panels: IVT CTBP; control lane
showing the migration of in vitro translated [35S]methionine-labeled
CtBP. Filled arrows points to HA-HDAC1 and the open arrow to
CtBP.
Fig. 4. Interaction between a 48 kDa cellular phosphoprotein and a
GST fusion protein expressing the last 44 amino acids of E1A.
[32P]Orthophosphate-labeled whole cell extract from U2OS cells was
bound to the indicated GST fusion proteins. Following electropho-
retic separation bound proteins were visualized by autoradiography.
A 48 kDa protein was speci¢cally pulled down by GSTctE1A. Sche-
matic representation of the GST fusion proteins are shown at the
top. IVT CtBP; control lane showing the migration of in vitro
translated [35S]methionine-labeled CtBP. M, protein size marker.
A. Sundqvist et al./FEBS Letters 429 (1998) 183^188186
3.5. CtBP interacts with the histone deacetylase HDAC1 both
in vitro and in vivo
In the Gal4-E1A experiments, the ability to recruit CtBP to
a promoter obscures CR1 transactivation [16]. Since histone
deacetylation appears to be an important mechanism control-
ling gene activity, we decided to investigate whether the re-
pressive e¡ect of CtBP involved recruitment of a histone de-
acetylase.
Using a pull-down experiment, we could demonstrate that
GSTCtBP interacted with in vitro translated HDAC1 as well
as full length E1A-243R (Fig. 5A). No binding was seen using
in vitro translated E1A-243RvCB (Fig. 5A). To investigate
whether CtBP also interacted with HDAC1 in vivo, U2OS
cells were transfected with a plasmid expressing haemaggluti-
nin (HA) tagged HDAC1. Immunoprecipitation with K-HA
mainly precipitated the HDAC1 protein (Fig. 5B). In contrast,
immunoprecipitation with antiserum against CtBP co-precipi-
tated proteins corresponding in size to both CtBP and
HDAC1 (Fig. 5B). To verify the presence of the HA tagged
HDAC1 in the K-CtBP precipitates, the protein gel was sub-
jected to Western blot analysis using K-HA. As can be seen in
the left panel of Fig. 5B, hybridization with K-HA detects
HDAC1 both in K-HA- and K-CtBP-precipitates from HA-
HDAC1 transfected cells. In summary, these results demon-
strate that CtBP and HDAC1 can form complexes both in
vitro and in vivo.
4. Discussion
The ability of E1A-243R to induce transcription has been
ascribed mainly to regions encoded by the ¢rst exon of the
E1A gene. Here we show that e⁄cient induction of the PCNA
promoter, in addition to ¢rst exon sequences, required the
presence of the CtBP binding region of the E1A second
exon. The CtBP binding region expressed as a separate second
exon encoded protein was able to restore transactivation by
the E1A-243RvCB deletion mutant, itself unable to bind
CtBP (Fig. 2), and furthermore able to activate transcription
in the absence of additional E1A proteins (Fig. 3). These
results suggests that E1A binding to CtBP alleviates a nega-
tive function of CtBP on PCNA promoter activity. We further
postulate that CtBP in the absence of E1A acts as a promoter
associated transcription repressor. In agreement with this, we
have previously shown that the Gal4CR1 transactivator [15] is
inactivated by the covalent fusion of the CtBP binding do-
main [16]. This repression was also relieved by co-expression
of a CtBP binding competent derivative of E1A [16]. By com-
peting for CtBP binding, excess of E1A could therefore dis-
rupt potential repressor complexes involving CtBP and cellu-
lar transcription factors. In the case of the E1A-243R
induction of the PCNA promoter, excess of the second exon
encoded protein surprisingly further increased the level of
transactivation. This may indicate that insu⁄cient amounts
of wild-type E1A-243R protein are expressed after transfec-
tion to sequester all CtBP.
The observation that CtBP associates with HDAC1 both in
vitro and in vivo suggests a possible mechanism by which
CtBP acts as a transcription repressor. Transcriptionally ac-
tive genes correlate with hyperacetylated histones and several
transcription factors recruit cofactors with histone acetyltrans-
ferase (HAT) activity [24]. Regulated gene expression involves
the opposing activities of HATs and at least three di¡erent
histone deacetylases (HDAC1^3) [25^27]. The HDACs are
members of large co-repressor complexes [28] which can be
recruited to di¡erent transcription factors [29,30]. In line with
what is known about co-repressor complexes we propose that
the CtBP-HDAC1 interaction constitutes a member of this
family of complexes.
The recently identi¢ed Drosophila CtBP (dCtBP) was shown
to interact with the Drosophila transcription repressors,
Knirps and Snail [31]. Interestingly, the E1A motif P-DLS-
K, which interacts with CtBP, is also present in Knirps and
Snail and furthermore essential for the interaction with dCtBP
[31]. These results support the model where E1A activates
transcription by sequestering of the inhibitory CtBP-
HDAC1 complex, thereby alleviating its repressive e¡ect on
transcription. Cloning of a cellular protein (CtIP) that binds
to the mammalian CtBP through the same motif was recently
described [32]. Since this interaction is disrupted by the second
exon of E1A, the CtBP-CtIP complex is suggested to relate to
the tumorigenic potential of transformed cells [32].
The E1A-243R responsive element in the PCNA promoter
has been mapped to a sequence around 345 to 359 called the
PCNA E1A-responsive element (PERE) [17]. PERE can bind
heterodimers between ATF-1 and CREB and it has been sug-
gested that E1A-243R induces transcription of the PCNA
promoter through the CREB-CBP pathway [22]. Activation
mediated by the second exon of E1A was shown here to be
independent of PERE. Our results therefore suggest that dual
mechanisms are involved in E1A-243R transactivation of the
PCNA promoter. In addition to the E1A exon 1 transactiva-
tion through PERE, the CtBP binding domain in the second
exon activates through the basal PCNA promoter. The basal
PCNA promoter element conferring response to the second
exon harbors an initiator site that binds YY1 [33]. YY1 has
been suggested to negatively regulate transcription by tether-
ing HDAC2 to the promoter [26]. It will therefore be of in-
terest to determine whether recruitment of the CtBP-HDAC1
complex also involves YY1.
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